274 related articles for article (PubMed ID: 23341447)
1. β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.
Watts AO; Verkaar F; van der Lee MM; Timmerman CA; Kuijer M; van Offenbeek J; van Lith LH; Smit MJ; Leurs R; Zaman GJ; Vischer HF
J Biol Chem; 2013 Mar; 288(10):7169-81. PubMed ID: 23341447
[TBL] [Abstract][Full Text] [Related]
2. ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins.
Matti C; Salnikov A; Artinger M; D'Agostino G; Kindinger I; Uguccioni M; Thelen M; Legler DF
Front Immunol; 2020; 11():720. PubMed ID: 32391018
[TBL] [Abstract][Full Text] [Related]
3. The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro.
Comerford I; Milasta S; Morrow V; Milligan G; Nibbs R
Eur J Immunol; 2006 Jul; 36(7):1904-16. PubMed ID: 16791897
[TBL] [Abstract][Full Text] [Related]
4. CCL20 is a novel ligand for the scavenging atypical chemokine receptor 4.
Matti C; D'Uonnolo G; Artinger M; Melgrati S; Salnikov A; Thelen S; Purvanov V; Strobel TD; Spannagel L; Thelen M; Legler DF
J Leukoc Biol; 2020 Jun; 107(6):1137-1154. PubMed ID: 32533638
[TBL] [Abstract][Full Text] [Related]
5. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.
Feng LY; Ou ZL; Wu FY; Shen ZZ; Shao ZM
Clin Cancer Res; 2009 May; 15(9):2962-70. PubMed ID: 19383822
[TBL] [Abstract][Full Text] [Related]
6. Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP-3beta/mCCL19: comparison to human CCX-CKR.
Townson JR; Nibbs RJ
Eur J Immunol; 2002 May; 32(5):1230-41. PubMed ID: 11981810
[TBL] [Abstract][Full Text] [Related]
7. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.
Kohout TA; Nicholas SL; Perry SJ; Reinhart G; Junger S; Struthers RS
J Biol Chem; 2004 May; 279(22):23214-22. PubMed ID: 15054093
[TBL] [Abstract][Full Text] [Related]
8. Endogenous expression of the atypical chemokine receptor CCX-CKR (CCRL1) gene in human embryonic kidney (HEK 293) cells.
Salimi P; Esmaeili A; Hashemi M; Behjati M
Mol Cell Biochem; 2016 Jan; 412(1-2):229-33. PubMed ID: 26699909
[TBL] [Abstract][Full Text] [Related]
9. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.
Byers MA; Calloway PA; Shannon L; Cunningham HD; Smith S; Li F; Fassold BC; Vines CM
J Immunol; 2008 Oct; 181(7):4723-32. PubMed ID: 18802075
[TBL] [Abstract][Full Text] [Related]
10. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.
Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM
Front Immunol; 2019; 10():2156. PubMed ID: 31572374
[TBL] [Abstract][Full Text] [Related]
11. Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia.
Catusse J; Leick M; Groch M; Clark DJ; Buchner MV; Zirlik K; Burger M
Mol Cancer; 2010 Nov; 9():297. PubMed ID: 21092185
[TBL] [Abstract][Full Text] [Related]
12. The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses.
Comerford I; Nibbs RJ; Litchfield W; Bunting M; Harata-Lee Y; Haylock-Jacobs S; Forrow S; Korner H; McColl SR
Blood; 2010 Nov; 116(20):4130-40. PubMed ID: 20562329
[TBL] [Abstract][Full Text] [Related]
13. The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT.
Harata-Lee Y; Turvey ME; Brazzatti JA; Gregor CE; Brown MP; Smyth MJ; Comerford I; McColl SR
Immunol Cell Biol; 2014 Nov; 92(10):815-24. PubMed ID: 25027038
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKR.
Vinet J; van Zwam M; Dijkstra IM; Brouwer N; van Weering HR; Watts A; Meijer M; Fokkens MR; Kannan V; Verzijl D; Vischer HF; Smit MJ; Leurs R; Biber K; Boddeke HW
Br J Pharmacol; 2013 Mar; 168(6):1375-87. PubMed ID: 23121557
[TBL] [Abstract][Full Text] [Related]
15. Expression of CCX CKR in pulmonary sarcoidosis.
Kriegova E; Tsyrulnyk A; Arakelyan A; Mrazek F; Ordeltova M; Petzmann S; Zatloukal J; Kolek V; du Bois RM; Popper H; Petrek M
Inflamm Res; 2006 Oct; 55(10):441-5. PubMed ID: 17109071
[TBL] [Abstract][Full Text] [Related]
16. Different effects of the different natural CC chemokine receptor 2b ligands on beta-arrestin recruitment, Gαi signaling, and receptor internalization.
Berchiche YA; Gravel S; Pelletier ME; St-Onge G; Heveker N
Mol Pharmacol; 2011 Mar; 79(3):488-98. PubMed ID: 21088225
[TBL] [Abstract][Full Text] [Related]
17. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
[TBL] [Abstract][Full Text] [Related]
18. CCX-CKR deficiency alters thymic stroma impairing thymocyte development and promoting autoimmunity.
Bunting MD; Comerford I; Seach N; Hammett MV; Asquith DL; Körner H; Boyd RL; Nibbs RJ; McColl SR
Blood; 2013 Jan; 121(1):118-28. PubMed ID: 23152546
[TBL] [Abstract][Full Text] [Related]
19. Generation of a panel of monoclonal antibodies against atypical chemokine receptor CCX-CKR by DNA immunization.
Takatsuka S; Sekiguchi A; Tokunaga M; Fujimoto A; Chiba J
J Pharmacol Toxicol Methods; 2011; 63(3):250-7. PubMed ID: 21184834
[TBL] [Abstract][Full Text] [Related]
20. Biased signaling at chemokine receptors.
Corbisier J; Galès C; Huszagh A; Parmentier M; Springael JY
J Biol Chem; 2015 Apr; 290(15):9542-54. PubMed ID: 25614627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
